ROBERT WANG, M.D.
Ophthalmology Physician · DALLAS, TX
Individual Active NPI 1568447175
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,133 | 66,748 | $12,883,389 | $4,811,237 | $3,790,844 |
| 2023 | 1,179 | 75,281 | $12,287,119 | $4,556,903 | $3,586,793 |
| 2022 | 1,270 | 26,336 | $11,690,859 | $4,227,713 | $3,327,496 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 50,123 | $35 | $28 |
| J0177 | Injection, aflibercept hd, 1 mg | 3,020 | $330 | $263 |
| 92134 | Imaging of retina | 2,763 | $40 | $30 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 2,358 | $147 | $117 |
| 67028 | Injection of drug into eye | 1,464 | $132 | $98 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 1,301 | $109 | $87 |
| 92012 | Established patient problem focused exam of visual system | 1,117 | $89 | $63 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 905 | $196 | $156 |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | 898 | $48 | $38 |
| 92014 | Established patient complete exam of visual system | 685 | $127 | $89 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 167 | $93 | $73 |
| 92004 | New patient complete exam of visual system | 156 | $148 | $103 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | L4795 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1083175558
- NPI 1386010122
- NPI 1679716948
- NPI 1538801063
- NPI 1114567476
- NPI 1275594376
- NPI 1124551163
- NPI 1093202004
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.